Table 3. Univariate Analysis of Pre-Treatment Host Variables ^a,b.

	Number of Patients	Number of survivors	P Value
Age			0.35
< 60, y	21 (32)	17 (21)
≥ 60, y	11 (32)	3 (11)
Gender			0.595
Male	20 (32)	15 (20)
Female	12 (32)	10 (12)
AST			0.774
< 100	12 (16)	8 (12)
≥ 100	4 (16)	3 (4)
ALT			0.411
< 50	9 (16)	7 (9)
≥ 50	7 (16)	4 (7)
ALP			0.043*
< 300	6 (14)	6 (6)
≥ 300	8 (14)	5 (8)
BIL			0.630
< 1	9 (14)	6 (9)
≥ 1	5 (14)	4 (5)
PT			0.682
< 13	16 (32)	14 (16)
≥ 13	16 (32)	12 (16)
Past chemotherapy			0.956
No	11 (18)	11 (11)
Yes	7 (18)	6 (7)
Past surgery			0.669
No	23 (26)	18(23)
Yes	3 (26)	2 (3)
Tumor size			0.010**
< 8, cm	18 (32)	17 (18)
≥ 8, cm	14 (32)	8 (14)
Tumor number			0.813
≤ 2	24 (32)	19 (24)
> 2	8 (32)	7 (8)
Tumor pattern			0.336
Hypo-vascular	30 (32)	24 (30)
Hyper-vascular	2 (32)	1 (2)
Tumor location			0.561
One lobe	27 (32)	20(27)
Both lobes	5 (32)	5 (5)
Involved segment			0.020**
< 2	12 (32)	12 (12)
≥ 2	20 (32)	13 (20)

^aAbbreviations: AST, aspartate aminotransferase; ALT, alanine aminoteransferase; ALP, alkaline phosphatase; BIL, bilirubin; PT, prothrombin time.

^bData are presented No. (%).